In this report, our team research the global Oncology/Anti-Cancer Drugs market by type, application, region and manufacturer 2013-2018 and forcast 2019-2024. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Oncology/Anti-Cancer Drugs in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Oncology/Anti-Cancer Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Amgen
AstraZeneca
Roche Diagnostics
GlaxoSmithKline
Merck
Novartis
AbbVie
Sanofi
EIMC United Pharmaceuticals
Actavis
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oncology/Anti-Cancer Drugs for each application, including
Blood Cancer (Leukaemia)
Breast Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Oncology/Anti-Cancer Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Oncology/Anti-Cancer Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 Amgen
4.1.1 Amgen Profiles
4.1.2 Amgen Product Information
4.1.3 Amgen Oncology/Anti-Cancer Drugs Business Performance
4.1.4 Amgen Oncology/Anti-Cancer Drugs Business Development and Market Status
4.2 AstraZeneca
4.2.1 AstraZeneca Profiles
4.2.2 AstraZeneca Product Information
4.2.3 AstraZeneca Oncology/Anti-Cancer Drugs Business Performance
4.2.4 AstraZeneca Oncology/Anti-Cancer Drugs Business Development and Market Status
4.3 Roche Diagnostics
4.3.1 Roche Diagnostics Profiles
4.3.2 Roche Diagnostics Product Information
4.3.3 Roche Diagnostics Oncology/Anti-Cancer Drugs Business Performance
4.3.4 Roche Diagnostics Oncology/Anti-Cancer Drugs Business Development and Market Status
4.4 GlaxoSmithKline
4.4.1 GlaxoSmithKline Profiles
4.4.2 GlaxoSmithKline Product Information
4.4.3 GlaxoSmithKline Oncology/Anti-Cancer Drugs Business Performance
4.4.4 GlaxoSmithKline Oncology/Anti-Cancer Drugs Business Development and Market Status
4.5 Merck
4.5.1 Merck Profiles
4.5.2 Merck Product Information
4.5.3 Merck Oncology/Anti-Cancer Drugs Business Performance
4.5.4 Merck Oncology/Anti-Cancer Drugs Business Development and Market Status
4.6 Novartis
4.6.1 Novartis Profiles
4.6.2 Novartis Product Information
4.6.3 Novartis Oncology/Anti-Cancer Drugs Business Performance
4.6.4 Novartis Oncology/Anti-Cancer Drugs Business Development and Market Status
4.7 AbbVie
4.7.1 AbbVie Profiles
4.7.2 AbbVie Product Information
4.7.3 AbbVie Oncology/Anti-Cancer Drugs Business Performance
4.7.4 AbbVie Oncology/Anti-Cancer Drugs Business Development and Market Status
4.8 Sanofi
4.8.1 Sanofi Profiles
4.8.2 Sanofi Product Information
4.8.3 Sanofi Oncology/Anti-Cancer Drugs Business Performance
4.8.4 Sanofi Oncology/Anti-Cancer Drugs Business Development and Market Status
4.9 EIMC United Pharmaceuticals
4.9.1 EIMC United Pharmaceuticals Profiles
4.9.2 EIMC United Pharmaceuticals Product Information
4.9.3 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Business Performance
4.9.4 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Business Development and Market Status
4.10 Actavis
4.10.1 Actavis Profiles
4.10.2 Actavis Product Information
4.10.3 Actavis Oncology/Anti-Cancer Drugs Business Performance
4.10.4 Actavis Oncology/Anti-Cancer Drugs Business Development and Market Status
6.1.1 Published Date: Jun. 2019 Oncology/Anti-Cancer Drugs Sales (K Units) and Share of Manufacturers 2013-2019
5 Market Performance for Manufacturers
5.1 Global Oncology/Anti-Cancer Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
5.2 Global Oncology/Anti-Cancer Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
5.3 Global Oncology/Anti-Cancer Drugs Price (USD/Unit) of Manufacturers 2013-2018
5.4 Global Oncology/Anti-Cancer Drugs Gross Margin of Manufacturers 2013-2018
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Oncology/Anti-Cancer Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.1.2 North America Oncology/Anti-Cancer Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.1.3 North America Oncology/Anti-Cancer Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.1.4 North America Oncology/Anti-Cancer Drugs Gross Margin of Manufacturers 2013-2018
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Oncology/Anti-Cancer Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.2.2 Europe Oncology/Anti-Cancer Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.2.3 Europe Oncology/Anti-Cancer Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.2.4 Europe Oncology/Anti-Cancer Drugs Gross Margin of Manufacturers 2013-2018
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.3.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.3.3 Asia-Pacific Oncology/Anti-Cancer Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.3.4 Asia-Pacific Oncology/Anti-Cancer Drugs Gross Margin of Manufacturers 2013-2018
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Oncology/Anti-Cancer Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.4.2 South America Oncology/Anti-Cancer Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.4.3 South America Oncology/Anti-Cancer Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.4.4 South America Oncology/Anti-Cancer Drugs Gross Margin of Manufacturers 2013-2018
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Oncology/Anti-Cancer Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.5.2 Middle East and Africa Oncology/Anti-Cancer Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.5.3 Middle East and Africa Oncology/Anti-Cancer Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.5.4 Middle East and Africa Oncology/Anti-Cancer Drugs Gross Margin of Manufacturers 2013-2018
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Regions and Countries 2013-2018
7.1.1 World Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Regions 2013-2018
7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
7.1.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.2 North America Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.3 Europe Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.4 South America Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.5 Middle East and Africa Oncology/Anti-Cancer Drugs Sales (K Units) and Share by Countries 2013-2018
7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
7.2.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.2 North America Oncology/Anti-Cancer Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.3 Europe Oncology/Anti-Cancer Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.4 South America Oncology/Anti-Cancer Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.5 Middle East and Africa Oncology/Anti-Cancer Drugs Revenue (M USD) and Share by Countries 2013-2018
7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
7.3.1 World Price (USD/Unit) by Regions 2013-2018
7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
7.3.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.2 North America Oncology/Anti-Cancer Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.3 Europe Oncology/Anti-Cancer Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.4 South America Oncology/Anti-Cancer Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.5 Middle East and Africa Oncology/Anti-Cancer Drugs Price (USD/Unit) by Countries 2013-2018
7.4 World Gross Margin by Regions and Countries 2013-2018
7.4.1 World Gross Margin by Regions 2013-2018
7.4.2 Regional Gross Margin and Share by Countries 2013-2018
7.4.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.2 North America Oncology/Anti-Cancer Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.3 Europe Oncology/Anti-Cancer Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.4 South America Oncology/Anti-Cancer Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.5 Middle East and Africa Oncology/Anti-Cancer Drugs Gross Margin and Share by Countries 2013-2018
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3 North America Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4 Europe Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5 South America Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6 Middle East and Africa Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Blood Cancer (Leukaemia) Industry
11.2 Breast Cancer Industry
11.3 Gastrointestinal Cancer Industry
12 Market Forecast 2019-2024
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
12.1.1 Global Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
12.1.2 Global Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate 2019-2024
12.1.3 Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.4 Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.5 Europe Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.6 South America Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.7 Middle East and Africa Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
12.2.1 Overall Market Performance
12.2.2 Chemotherapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.3 Targeted Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.4 Immunotherapy (Biologic Therapy) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.5 Hormonal Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3 Sales by Application 2019-2024
12.3.1 Overall Market Performance
12.3.2 Blood Cancer (Leukaemia) Sales and and Growth Rate 2019-2024
12.3.3 Breast Cancer Sales and and Growth Rate 2019-2024
12.3.4 Gastrointestinal Cancer Sales and and Growth Rate 2019-2024
12.3.5 Respiratory/Lung Cancer Sales and and Growth Rate 2019-2024
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Oncology/Anti-Cancer Drugs Price (USD/Unit) Trend 2019-2024
12.4.2 Global Oncology/Anti-Cancer Drugs Gross Profit Trend 2019-2024
13 Conclusion
List of Tables and Figures
Figure Product Picture of Oncology/Anti-Cancer Drugs
Table Product Specifications of Oncology/Anti-Cancer Drugs
Table Manufacturers List in the Report
Table Manufacturers Market Share 2013-2018
Table Regions Overview in the Report
Table Product Type and Standard
Table Type Overview
Table Product Application and Standard
Table Application Overview in the Report
Figure Industry Chain Structure of Oncology/Anti-Cancer Drugs
Table Industry News List of Oncology/Anti-Cancer Drugs
Figure New Project SWOT Analysis of Oncology/Anti-Cancer Drugs
Table World 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Figure World Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2013
Figure World Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2018
Table World 2013-2018 Oncology/Anti-Cancer DrugsRevenue (M USD) by Type
Figure World Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2013
Figure World Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2018
Table World Chemotherapy Sales (K Units) and Growth Rate
Figure World Chemotherapy Sales (K Units) and Growth Rate
Table World Chemotherapy Revenue (M USD) and Growth Rate
Figure World Chemotherapy Revenue (M USD) and Growth Rate
Table World Targeted Therapy Sales (K Units) and Growth Rate
Figure World Targeted Therapy Sales (K Units) and Growth Rate
Table World Targeted Therapy Revenue (M USD) and Growth Rate
Figure World Targeted Therapy Revenue (M USD) and Growth Rate
Table World Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Figure World Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Table World Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Figure World Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Table World Hormonal Therapy Sales (K Units) and Growth Rate
Figure World Hormonal Therapy Sales (K Units) and Growth Rate
Table World Hormonal Therapy Revenue (M USD) and Growth Rate
Figure World Hormonal Therapy Revenue (M USD) and Growth Rate
Table North America 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Figure North America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2013
Figure North America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2018
Table North America 2013-2018 Oncology/Anti-Cancer DrugsRevenue (M USD) by Type
Figure North America Oncology/Anti-Cancer Drugs Revenue Market Share (%) by Type in 2013
Figure North America Oncology/Anti-Cancer Drugs Revenue Market Share (%) by Type in 2018
Table North America Chemotherapy Sales (K Units) and Growth Rate
Figure North America Chemotherapy Sales (K Units) and Growth Rate
Table North America Chemotherapy Revenue (M USD) and Growth Rate
Figure North America Chemotherapy Revenue (M USD) and Growth Rate
Table North America Targeted Therapy Sales (K Units) and Growth Rate
Figure North America Targeted Therapy Sales (K Units) and Growth Rate
Table North America Targeted Therapy Revenue (M USD) and Growth Rate
Figure North America Targeted Therapy Revenue (M USD) and Growth Rate
Table North America Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Figure North America Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Table North America Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Figure North America Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Table North America Hormonal Therapy Sales (K Units) and Growth Rate
Figure North America Hormonal Therapy Sales (K Units) and Growth Rate
Table North America Hormonal Therapy Revenue (M USD) and Growth Rate
Figure North America Hormonal Therapy Revenue (M USD) and Growth Rate
Table Europe 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Figure Europe Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2013
Figure Europe Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2018
Table Europe 2013-2018 Oncology/Anti-Cancer DrugsRevenue (M USD) by Type
Figure Europe Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2013
Figure Europe Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2018
Table Europe Chemotherapy Sales (K Units) and Growth Rate
Figure Europe Chemotherapy Sales (K Units) and Growth Rate
Table Europe Chemotherapy Revenue (M USD) and Growth Rate
Figure Europe Chemotherapy Revenue (M USD) and Growth Rate
Table Europe Targeted Therapy Sales (K Units) and Growth Rate
Figure Europe Targeted Therapy Sales (K Units) and Growth Rate
Table Europe Targeted Therapy Revenue (M USD) and Growth Rate
Figure Europe Targeted Therapy Revenue (M USD) and Growth Rate
Table Europe Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Figure Europe Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Table Europe Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Figure Europe Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Table Europe Hormonal Therapy Sales (K Units) and Growth Rate
Figure Europe Hormonal Therapy Sales (K Units) and Growth Rate
Table Europe Hormonal Therapy Revenue (M USD) and Growth Rate
Figure Europe Hormonal Therapy Revenue (M USD) and Growth Rate
Table Asia-Pacific 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2013
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2018
Table Asia-Pacific 2013-2018 Oncology/Anti-Cancer DrugsRevenue (M USD) by Type
Figure Asia-Pacific Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2013
Figure Asia-Pacific Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2018
Table Asia-Pacific Chemotherapy Sales (K Units) and Growth Rate
Figure Asia-Pacific Chemotherapy Sales (K Units) and Growth Rate
Table Asia-Pacific Chemotherapy Revenue (M USD) and Growth Rate
Figure Asia-Pacific Chemotherapy Revenue (M USD) and Growth Rate
Table Asia-Pacific Targeted Therapy Sales (K Units) and Growth Rate
Figure Asia-Pacific Targeted Therapy Sales (K Units) and Growth Rate
Table Asia-Pacific Targeted Therapy Revenue (M USD) and Growth Rate
Figure Asia-Pacific Targeted Therapy Revenue (M USD) and Growth Rate
Table Asia-Pacific Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Figure Asia-Pacific Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Table Asia-Pacific Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Figure Asia-Pacific Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Table Asia-Pacific Hormonal Therapy Sales (K Units) and Growth Rate
Figure Asia-Pacific Hormonal Therapy Sales (K Units) and Growth Rate
Table Asia-Pacific Hormonal Therapy Revenue (M USD) and Growth Rate
Figure Asia-Pacific Hormonal Therapy Revenue (M USD) and Growth Rate
Table South America 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Figure South America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2013
Figure South America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2018
Table South America 2013-2018 Oncology/Anti-Cancer DrugsRevenue (M USD) by Type
Figure South America Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2013
Figure South America Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2018
Table South America Chemotherapy Sales (K Units) and Growth Rate
Figure South America Chemotherapy Sales (K Units) and Growth Rate
Table South America Chemotherapy Revenue (M USD) and Growth Rate
Figure South America Chemotherapy Revenue (M USD) and Growth Rate
Table South America Targeted Therapy Sales (K Units) and Growth Rate
Figure South America Targeted Therapy Sales (K Units) and Growth Rate
Table South America Targeted Therapy Revenue (M USD) and Growth Rate
Figure South America Targeted Therapy Revenue (M USD) and Growth Rate
Table South America Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Figure South America Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Table South America Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Figure South America Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Table South America Hormonal Therapy Sales (K Units) and Growth Rate
Figure South America Hormonal Therapy Sales (K Units) and Growth Rate
Table South America Hormonal Therapy Revenue (M USD) and Growth Rate
Figure South America Hormonal Therapy Revenue (M USD) and Growth Rate
Table Middle East and Africa 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Figure Middle East and Africa Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2013
Figure Middle East and Africa Oncology/Anti-Cancer Drugs Sales Market Share (%) by Type in 2018
Table Middle East and Africa 2013-2018 Oncology/Anti-Cancer DrugsRevenue (M USD) by Type
Figure Middle East and Africa Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2013
Figure Middle East and Africa Oncology/Anti-Cancer DrugsRevenue Market Share (%) by Type in 2018
Table Middle East and Africa Chemotherapy Sales (K Units) and Growth Rate
Figure Middle East and Africa Chemotherapy Sales (K Units) and Growth Rate
Table Middle East and Africa Chemotherapy Revenue (M USD) and Growth Rate
Figure Middle East and Africa Chemotherapy Revenue (M USD) and Growth Rate
Table Middle East and Africa Targeted Therapy Sales (K Units) and Growth Rate
Figure Middle East and Africa Targeted Therapy Sales (K Units) and Growth Rate
Table Middle East and Africa Targeted Therapy Revenue (M USD) and Growth Rate
Figure Middle East and Africa Targeted Therapy Revenue (M USD) and Growth Rate
Table Middle East and Africa Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Figure Middle East and Africa Immunotherapy (Biologic Therapy) Sales (K Units) and Growth Rate
Table Middle East and Africa Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Figure Middle East and Africa Immunotherapy (Biologic Therapy) Revenue (M USD) and Growth Rate
Table Middle East and Africa Hormonal Therapy Sales (K Units) and Growth Rate
Figure Middle East and Africa Hormonal Therapy Sales (K Units) and Growth Rate
Table Middle East and Africa Hormonal Therapy Revenue (M USD) and Growth Rate
Figure Middle East and Africa Hormonal Therapy Revenue (M USD) and Growth Rate
Table World 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Figure World Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2013
Figure World Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2018
Table World Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Figure World Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Table World Breast Cancer Sales (K Units) and Growth Rate
Figure World Breast Cancer Sales (K Units) and Growth Rate
Table World Gastrointestinal Cancer Sales (K Units) and Growth Rate
Figure World Gastrointestinal Cancer Sales (K Units) and Growth Rate
Table World Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Figure World Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Table North America 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Figure North America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2013
Figure North America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2018
Table North America Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Figure North America Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Table North America Breast Cancer Sales (K Units) and Growth Rate
Figure North America Breast Cancer Sales (K Units) and Growth Rate
Table North America Gastrointestinal Cancer Sales (K Units) and Growth Rate
Figure North America Gastrointestinal Cancer Sales (K Units) and Growth Rate
Table North America Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Figure North America Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Table Europe 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Figure Europe Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2013
Figure Europe Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2018
Table Europe Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Figure Europe Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Table Europe Breast Cancer Sales (K Units) and Growth Rate
Figure Europe Breast Cancer Sales (K Units) and Growth Rate
Table Europe Gastrointestinal Cancer Sales (K Units) and Growth Rate
Figure Europe Gastrointestinal Cancer Sales (K Units) and Growth Rate
Table Europe Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Figure Europe Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Table Asia-Pacific 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2013
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2018
Table Asia-Pacific Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Figure Asia-Pacific Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Table Asia-Pacific Breast Cancer Sales (K Units) and Growth Rate
Figure Asia-Pacific Breast Cancer Sales (K Units) and Growth Rate
Table Asia-Pacific Gastrointestinal Cancer Sales (K Units) and Growth Rate
Figure Asia-Pacific Gastrointestinal Cancer Sales (K Units) and Growth Rate
Table Asia-Pacific Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Figure Asia-Pacific Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Table South America 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Figure South America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2013
Figure South America Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2018
Table South America Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Figure South America Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Table South America Breast Cancer Sales (K Units) and Growth Rate
Figure South America Breast Cancer Sales (K Units) and Growth Rate
Table South America Gastrointestinal Cancer Sales (K Units) and Growth Rate
Figure South America Gastrointestinal Cancer Sales (K Units) and Growth Rate
Table South America Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Figure South America Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Table Middle East and Africa 2013-2018 Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Figure Middle East and Africa Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2013
Figure Middle East and Africa Oncology/Anti-Cancer Drugs Sales Market Share (%) by Application in 2018
Table Middle East and Africa Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Figure Middle East and Africa Blood Cancer (Leukaemia) Sales (K Units) and Growth Rate
Table Middle East and Africa Breast Cancer Sales (K Units) and Growth Rate
Figure Middle East and Africa Breast Cancer Sales (K Units) and Growth Rate
Table Middle East and Africa Gastrointestinal Cancer Sales (K Units) and Growth Rate
Figure Middle East and Africa Gastrointestinal Cancer Sales (K Units) and Growth Rate
Table Middle East and Africa Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Figure Middle East and Africa Respiratory/Lung Cancer Sales (K Units) and Growth Rate
Table Amgen Profiles
Table Amgen Product Information
Table Amgen Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Amgen Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table Amgen Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table AstraZeneca Profiles
Table AstraZeneca Product Information
Table AstraZeneca Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table AstraZeneca Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table AstraZeneca Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table Roche Diagnostics Profiles
Table Roche Diagnostics Product Information
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Product Information
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table Merck Profiles
Table Merck Product Information
Table Merck Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Merck Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table Merck Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table Novartis Profiles
Table Novartis Product Information
Table Novartis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Novartis Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table Novartis Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table AbbVie Profiles
Table AbbVie Product Information
Table AbbVie Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table AbbVie Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table AbbVie Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table Sanofi Profiles
Table Sanofi Product Information
Table Sanofi Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Sanofi Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table Sanofi Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table EIMC United Pharmaceuticals Profiles
Table EIMC United Pharmaceuticals Product Information
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table Actavis Profiles
Table Actavis Product Information
Table Actavis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Actavis Oncology/Anti-Cancer Drugs Sales Change 2013-2018
Table Actavis Oncology/Anti-Cancer Drugs Market Status Change 2013-2018
Table World Oncology/Anti-Cancer Drugs Sales (K Units) of Manufacturers 2013-2018
Table World Oncology/Anti-Cancer Drugs Sales Share of Manufacturers 2013-2018
Figure World Oncology/Anti-Cancer Drugs Sales Share in 2013
Cross-segment Market Size and Analysis for
Mentioned Segments
